Hideaki Nomura is currently President & CEO for FUJIFILM KYOWA KIRIN BIOLOGICS (FKB). FKB is a joint venture company of FUJIFILM, a global film company, and KYOWA HAKKO KIRIN, a Japanese pharmaceutical company. FKB focuses on biosimilar manufacturing and development. He has around 30 years experiences in pharmaceutical industries. Prior this position, Hideaki was a head of strategic planning in Nephrology field of KYOWA HAKKO KIRIN. He has over ten years of experiences in portfolio management and product management in oncology area. Hideaki had responsibilities for G-CSF, Peg-G-CSF, other products, and medical device in oncology field to develop and/or market. During his scientific career, Hideaki held several key roles in pharmaceutical division of KIRIN BREWERY for formulation development, drug delivery system research, good manufacturing practice and operations.